These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 8587285)

  • 1. Clinical correlation between renal allograft failure and hyperlipidemia.
    Guijarro C; Massy ZA; Kasiske BL
    Kidney Int Suppl; 1995 Dec; 52():S56-9. PubMed ID: 8587285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical predictors of chronic renal allograft rejection.
    Massy ZA; Guijarro C; Kasiske BL
    Kidney Int Suppl; 1995 Dec; 52():S85-8. PubMed ID: 8587291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical utility of antilipidemic therapies in chronic renal allograft failure.
    Wanner C; Bartens W; Galle J
    Kidney Int Suppl; 1995 Dec; 52():S60-2. PubMed ID: 8587286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic factors and outcome of organ transplantation.
    Dimény E
    Scand J Urol Nephrol Suppl; 1994; 159():1-74. PubMed ID: 7817159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early acute rejection does not affect chronic allograft nephropathy and death censored graft failure.
    He X; Johnston A
    Transplant Proc; 2004 Dec; 36(10):2993-6. PubMed ID: 15686679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical correlates to chronic renal allograft rejection.
    Kasiske BL
    Kidney Int Suppl; 1997 Dec; 63():S71-4. PubMed ID: 9407426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pathogenesis of chronic renal allograft dysfunction].
    Morozumi K; Takeda A; Uchida K
    Hinyokika Kiyo; 2002 Nov; 48(11):673-7. PubMed ID: 12512140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic renal allograft failure: clinical overview. The Leuven Collaborative Group for Transplantation.
    Peeters J; Roels L; Vanrenterghem Y
    Kidney Int Suppl; 1995 Dec; 52():S97-101. PubMed ID: 8587294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peritubular capillary C4d staining in late acute renal allograft rejection--is it relevant?
    Satoskar AA; Lehman AM; Nadasdy GM; Sedmak DD; Pesavento TE; Henry ML; Pelletier RP; Ferguson RM; Nadasdy T
    Clin Transplant; 2008; 22(1):61-7. PubMed ID: 18217907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of C0 and C2 levels with lipid profiles in adolescent renal transplant recipients in the early and late posttransplant periods.
    Soylu A; Kavukçu S; Türkmen MA; Kasap B; Soylu A; Bora S; Gülay H
    Transplant Proc; 2006 Jun; 38(5):1286-9. PubMed ID: 16797283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Risk factors of chronic rejection in kidney transplantation, results of a single center study].
    Delmas S; Picot MC; Vergnes C; Cristol JP; Mourad G
    Nephrologie; 1999; 20(3):153-8. PubMed ID: 10418005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Causes of late renal transplant dysfunction].
    Szabó A; Müller V
    Orv Hetil; 2002 Dec; 143(51):2811-9. PubMed ID: 12638307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and immunohistochemical findings of subclinical kidney allograft rejection and its association with graft outcome.
    Veronese FV; Noronha IL; Manfro RC; Edelweiss MI; Goldberg J; Gonçalves LF
    Clin Transplant; 2004 Aug; 18(4):357-64. PubMed ID: 15233810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Role of transforming growth factor beta-1 gene polymorphisms in the development of chronic allograft nephropathy in renal transplant recipients].
    Iñigo P; Lario S; Campistol JM; Bescós M; Campos B; Oppenheimer F
    Nefrologia; 2003; 23(4):312-20. PubMed ID: 14558330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Post-transplant hypertension and chronic renal allograft failure.
    Paul LC; Benediktsson H
    Kidney Int Suppl; 1995 Dec; 52():S34-7. PubMed ID: 8587280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Five-year study of tacrolimus as secondary intervention versus continuation of cyclosporine in renal transplant patients at risk for chronic renal allograft failure.
    Jevnikar A; Arlen D; Barrett B; Boucher A; Cardella C; Cockfield SM; Rush D; Paraskevas S; Shapiro J; Shoker A; Yilmaz S; Zaltzman JS; Kiberd B
    Transplantation; 2008 Oct; 86(7):953-60. PubMed ID: 18852662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of early cyclosporine levels on kidney allograft rejection.
    Johnson EM; Canafax DM; Gillingham KJ; Humar A; Pandian K; Kerr SR; Najarian JS; Matas AJ
    Clin Transplant; 1997 Dec; 11(6):552-7. PubMed ID: 9408683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term results in renal transplant patients with allograft dysfunction after switching from calcineurin inhibitors to sirolimus.
    Bumbea V; Kamar N; Ribes D; Esposito L; Modesto A; Guitard J; Nasou G; Durand D; Rostaing L
    Nephrol Dial Transplant; 2005 Nov; 20(11):2517-23. PubMed ID: 15985508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin 8 -251T>A and Interferon gamma +874A>T polymorphism: potential predictors of allograft outcome in renal transplant recipients from north India.
    Singh R; Kesarwani P; Ahirwar DK; Kapoor R; Mittal RD
    Transpl Immunol; 2009 May; 21(1):13-7. PubMed ID: 19189859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Causes of late renal allograft loss: chronic allograft dysfunction, death, and other factors.
    Kreis HA; Ponticelli C
    Transplantation; 2001 Jun; 71(11 Suppl):SS5-9. PubMed ID: 11583489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.